

Storage, green fuels and domestic manufacturing will drive the next phase of India’s clean energy transition, says Sumant Sinha, Founder, Chairman and CEO of ReNew.

Delhi-based dermatologist Dr Deepali Bhardwaj explains the science behind healthy skin, separating medical evidence from popular skincare trends.

Companies are unlikely to move manufacturing to the US overnight. Instead, they are expected to focus on product portfolios, export diversification and selective capacity expansion while awaiting clar...

Hospital chain says higher occupancy, acquisitions and expansion into new markets will drive growth; July 29 IPO to leave it virtually debt-free.
Dr. Reddy's Laboratories reported a weak first quarter as net profit fell 69% year-on-year, hit by lower sales of its blockbuster cancer drug lenalidomide and a one-time provision related to a semaglu...

Experts say COVID-19 should not be dismissed as just another seasonal flu. While widespread immunity has reduced the severity of infection, the virus continues to hospitalise and kill vulnerable peopl...

The cloud major has added new capabilities to Bedrock, Kiro and Strands Agents as it expands its AI software development portfolio.
India's pharmaceutical sector is back in focus after U.S. President Donald Trump proposed a 100% tariff on generic drug imports, while offering a two-year grace period before implementation. Business ...

Organised diagnostic companies also reported revenue growth of more than 15%, with average EBITDA margins above 25%.

Industry says Indian companies have already invested in US manufacturing and remain critical to America’s generic drug supply, even as Trump pushes for greater domestic production.
Ancient Silk Route to Tibet reopens: India-China trade through Shipki La resumes after six years
$100,000-a-month: Trump Media unveils Truth API for investors, draws calls for SEC probe
No more waiting for an LPG connection? BPCL rolls out Bharatgas Lite ZIP with 10-kg fibre composite cylinder
When gods ruled empires: 4 forgotten religions that shaped civilizations and then vanished
Mazagon Dock shares: Brokerages see up to 37% upside after Q1 FY27 results; check latest target prices
Mukul Agrawal signals exit this multibagger stock after nearly 9x rall; is it still a buy?




